POSTER PRESENTATIONS: Posters Friday, 12 April 2019Viral hepatitis B/D: therapyFRI-159-Can HBcrAg and pre-genomic HBV RNA predict the risk of ALT flares after nucleoside analogue therapy withdrawal: delineating the clinical utility of new biomarkers?
Viral hepatitis B/D: therapy
References (0)
Cited by (0)
Copyright © 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.